BOOTH #D2826

Looking for a way to improve the limit of detection for low-frequency CNVs and mutations?

Explore NuProbe’s Oncology Research Technologies at PMWC – Proprietary technologies to enable ultrasensitive detection while overcoming the challenges of current methods.

CLINICAL & RESEARCH TOOLS SESSION

Rapid Custom Development Program for Oncology Translational Research

WEDNESDAY, JUNE 29, 2022 | 9 AM | TRACK 6 | SANTA CLARA CONVENTION CENTER

In this talk, we will discuss a highly sensitive method for the ultrasensitive detection and quantification of somatic Copy Number Variations (CNVs) and mutations from tissue and liquid biopsy samples. Additionally, we will introduce NuProbe’s custom assay development and validation solutions for oncology research applications.

Register Now





    Speaker

    Nick Gallerani, Ph.D.

    SENIOR BUSINESS DEVELOPMENT ASSOCIATE
    Nicholas Gallerani, Ph.D., serves as a Senior Business Development Associate at NuProbe. Prior to joining NuProbe, he received his Ph.D. in Pathobiology and Molecular Medicine from Columbia University and was a Fellow at Columbia Technology Ventures, where he assessed new technologies generated by their research labs.